BORNEM PHARMA
0465.495.476 · rovalta.com · 09/11/2026
BORNEM PHARMA
Financial year 2025 · Closed on 31/12/2025
Overview
Identity
Source · BCE/KBOBORNEM PHARMA is a Private limited company incorporated in 1999. Its main activity is: Dispensing chemist in specialised stores. Its registered office is in Bornem. It employs on average 2,4 ETP workers (FTE).
- Legal situation
- Normal situation
- BCE/KBO no. / VAT
- BE 0465.495.476
- Incorporation
- 24/03/1999
- Legal form
- Private limited company
- Registered office
- Boomstraat(BOR) 7 box gvl
2880 Bornem · FlandreSee on map - Contributed capital
- 18 600,00 €
- Latest accounts
- 31/12/2025
- Average workforce
- 2,4 ETP
Joint committees (1)
- 313
Financials
Source · NBB, 20 filingsTrend over 19 financial years
| 2025 | 2024 | 2023 | 2022 | 2021 | |||||
|---|---|---|---|---|---|---|---|---|---|
| Income statement | |||||||||
| Gross margin | 454,3 k € | +19.8% | 379,1 k € | +14.7% | 330,4 k € | +6.7% | 309,7 k € | +26.4% | 245 k € |
| EBITDA | 288,6 k € | +3.8% | 278,1 k € | +34.8% | 206,3 k € | +5.0% | 196,3 k € | +47.5% | 133,1 k € |
| Operating result | 273,4 k € | +4.0% | 263 k € | +36.1% | 193,3 k € | +5.4% | 183,5 k € | +52.1% | 120,6 k € |
| Net result | 248 k € | +2.0% | 243,1 k € | +36.1% | 178,6 k € | +5.5% | 169,3 k € | +56.7% | 108 k € |
| Balance sheet | |||||||||
| Equity | 303,3 k € | +18.8% | 255,3 k € | +11.9% | 228,2 k € | +4.9% | 217,6 k € | +4.5% | 208,3 k € |
| Total assets | 1,3 M € | +7.6% | 1,2 M € | +10.3% | 1,1 M € | +2.2% | 1 M € | +9.8% | 953,2 k € |
| Cash | 434,9 k € | +30.2% | 334 k € | +13.6% | 294,2 k € | +2.9% | 285,8 k € | +18.6% | 241 k € |
| Debts | 966,7 k € | +4.6% | 924,6 k € | +9.8% | 842,1 k € | +1.5% | 829,3 k € | +11.5% | 744,1 k € |
| Other | |||||||||
| Workforce | 2,4 ETP | +60.0% | 1,5 ETP | -6.3% | 1,6 ETP | -20.0% | 2,0 ETP | 0.0% | 2,0 ETP |
Valuation
Indicative valuation
As an indication, this company is worth
Board of directors
Source · NBB, accounts to 31/12/20251 active · 2 ended
Active mandates
| Director | Mandates in this company | Period | Other mandatescurrentendedstruck offbankruptcies |
|---|---|---|---|
| Directorsince 01/09/2019 |
Ended mandates
| Director | Mandates in this company | Period | Other mandatescurrentendedstruck offbankruptcies |
|---|---|---|---|
Julius Merckx | Manager23/03/1999 → 2018 accounts | ||
Julius Antoon Francina Merckx | Directoruntil 31/08/2019 |
Financials
Full financial information
Source · NBB| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|
| Type of account | Abridged model | Abridged model | Abridged model | Abridged model | Abridged model | Abridged model |
| Start of the financial year | 01/01/2025 | 01/01/2024 | 01/01/2023 | 01/01/2022 | 01/01/2021 | 01/01/2020 |
| Closing of the financial year | 31/12/2025 | 31/12/2024 | 31/12/2023 | 31/12/2022 | 31/12/2021 | 31/12/2020 |
| Length of the financial year | 12 months | 12 months | 12 months | 12 months | 12 months | 12 months |
| Filing date | 06/08/2026 | 01/08/2025 | 15/08/2024 | 24/08/2023 | 16/08/2022 | 18/08/2021 |
| General meeting | 18/06/2026 | 19/06/2025 | 20/06/2024 | 15/06/2023 | 16/06/2022 | 17/06/2021 |
| Currency of the financial year | EUR | EUR | EUR | EUR | EUR | EUR |
| NBB quality label | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls |
Financial ratios
Source · NBBLooking for more information about this company?
Try for freeAnnual accounts filings
Source · NBB, 20 filings| Model | Closing | General meeting | Filed | Language | Document |
|---|---|---|---|---|---|
| Abridged model | 31/12/2025 | 18/06/2026 | 06/08/2026 | Dutch | |
| Abridged model | 31/12/2024 | 19/06/2025 | 01/08/2025 | Dutch | |
| Abridged model | 31/12/2023 | 20/06/2024 | 15/08/2024 | Dutch | |
| Abridged model | 31/12/2022 | 15/06/2023 | 24/08/2023 | Dutch | |
| Abridged model | 31/12/2021 | 16/06/2022 | 16/08/2022 | Dutch | |
| Abridged model | 31/12/2020 | 17/06/2021 | 18/08/2021 | Dutch | |
| Abridged model | 31/12/2019 | 18/06/2020 | 04/08/2020 | Dutch | |
| Abridged model | 31/12/2018 | 20/06/2019 | 17/07/2019 | Dutch | |
| Abridged model | 31/12/2017 | 21/06/2018 | 10/08/2018 | Dutch | |
| Abridged model | 31/12/2016 | 15/06/2017 | 31/08/2017 | Dutch | |
| Abridged model | 31/12/2015 | 16/06/2016 | 28/07/2016 | Dutch | |
| Abridged model | 31/12/2014 | 18/06/2015 | 29/07/2015 | Dutch | |
| Abridged model | 31/12/2013 | 17/06/2014 | 31/07/2014 | Dutch | |
| Abridged model | 31/12/2012 | 20/03/2013 | 26/07/2013 | Dutch | |
| Abridged model | 31/12/2011 | 21/06/2012 | 02/08/2012 | Dutch | |
| Abridged model | 31/12/2010 | 26/05/2011 | 02/08/2011 | Dutch | |
| Abridged model | 31/12/2009 | 17/06/2010 | 23/07/2010 | Dutch | |
| Abridged model | 31/12/2008 | 18/06/2009 | 29/07/2009 | Dutch | |
| Abridged model | 31/12/2007 | 19/06/2008 | 21/08/2008 | Dutch | |
| Abridged model | 31/12/2006 | 21/06/2007 | 06/07/2007 | Dutch |
Valuation
Indicative valuation
As an indication, this company is worth
between 1 M€ and 2,5 M€
The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.
Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.
Directors & structure
Board of directors
Source · NBB, accounts to 31/12/20251 active · 2 ended
Active mandates
| Director | Mandates in this company | Period | Other mandatescurrentendedstruck offbankruptcies |
|---|---|---|---|
| Directorsince 01/09/2019 |
Ended mandates
| Director | Mandates in this company | Period | Other mandatescurrentendedstruck offbankruptcies |
|---|---|---|---|
Julius Merckx | Manager23/03/1999 → 2018 accounts | ||
Julius Antoon Francina Merckx | Directoruntil 31/08/2019 |
Ownership and network
Looking for more information about this company?
Try for freePublications
Belgian Official Gazette publications
Source · Belgian Official GazetteSimilar companies
Similar companies
A company's peers, by sector and size, are included in the Business plan.
See the Business planTimeline
Timeline
Source · CBE, NBB annual accountsRegistered offices
Source · NBB annual accounts, CBE| Registered address | Period | Source |
|---|---|---|
| Boomstraat(BOR) 7 bte gvl, 2880 BornemCurrent | accounts 2025 | Accounts 2025 · 2026-00384840 |
| Boomstraat(bor) 7/gvl, 2880 Bornem | accounts 2022 → 2024 | Accounts 2024 · 2025-00353059 |
| Boomstraat(bor) 7 bte gvl, 2880 Bornem | accounts 2021 | Accounts 2021 · 2022-20289341 |
Company names
Source · NBB annual accounts, CBE| Name | Period | Source |
|---|---|---|
| BORNEM PHARMACurrent | accounts 2021 → 2025 | Accounts 2025 · 2026-00384840 |
Events
- 2025Annual accounts 2025248 k €↑
- 2024Annual accounts 2024243,1 k €↑
- 2023Annual accounts 2023178,6 k €↑
- 2022Annual accounts 2022169,3 k €↑
- 2021Annual accounts 2021108 k €↑
- 2020Annual accounts 202091 k €↑
- 2019Annual accounts 2019-9,5 k €↓
- 2017Annual accounts 201729,8 k €↓
- 2016Annual accounts 201637,8 k €↑
- 2015Annual accounts 201526,1 k €↑
- 2014Annual accounts 201411,2 k €↓
- 2013Annual accounts 201340,3 k €↓
- 2012Annual accounts 201250,9 k €↑
- 2011Annual accounts 201149,5 k €↑
- 2010Annual accounts 201028,8 k €↑
- 2009Annual accounts 200915,4 k €↓
- 2008Annual accounts 200819,9 k €↓
- 2007Annual accounts 200722,4 k €↑
- 2006Annual accounts 20067,9 k €
- 24/03/1999IncorporationPrivate limited company